Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Project Updates and Milestones news
(page 58)
19 October 2025
Johnson & Johnson's Subcutaneous Amivantamab Shows 45% Response Rate in Head and Neck Cancer
Subcutaneous amivantamab offers rapid, durable responses in head and neck cancer, with 82% tumor shrinkage and a median response duration of 7.2 months.
19 October 2025
Raludotatug Deruxtecan Shows 50.5% Response in Platinum-Resistant Ovarian Cancer, Reports Daiichi Sankyo and Merck
Raludotatug deruxtecan achieved a 50.5% response rate in phase 2 for platinum-resistant ovarian cancer, with a 5.6 mg/kg dose selected for phase 3.
18 October 2025
Genmab Reports Positive Phase 1/2 Trial Results for Rina-S in Advanced Endometrial Cancer
Rina-S shows 50% response rate in advanced endometrial cancer trial; FDA grants Breakthrough Therapy Designation.
18 October 2025
Merck and Eisai: KEYTRUDA and LENVIMA Show 5-Year Survival Benefit in Advanced Endometrial Carcinoma
KEYTRUDA and LENVIMA improve 5-year survival rates in advanced endometrial carcinoma compared to chemotherapy, with consistent results across patient subgroups.
18 October 2025
Merck's KEYTRUDA Plus Chemotherapy Reduces Disease Progression Risk in Platinum-Resistant Ovarian Cancer
KEYTRUDA with chemotherapy shows significant survival benefits in platinum-resistant ovarian cancer, leading to FDA priority review for expanded use.
17 October 2025
FDA Approves Novo Nordisk's Oral Semaglutide for CV Risk Reduction in High-Risk Type 2 Diabetes Adults
Oral semaglutide reduces major cardiovascular events in high-risk type 2 diabetes patients, showing a 14% risk reduction over 4 years, with consistent safety profile.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
17 October 2025
Roche's Gazyva/Gazyvaro Gains EU CHMP Nod for Lupus Nephritis
CHMP backs Gazyva/Gazyvaro for lupus nephritis, showing superior renal response in trials. Awaiting European Commission decision.
17 October 2025
Mitsubishi Chemical's SoarnoL EVOH Resins Approved for Recyclability in Multilayer Films
RecyClass confirms multilayer films with up to 10% SoarnoL EVOH resins are recyclable with PE flexibles, supporting sustainable packaging and circular economy efforts.
16 October 2025
RIFT and Bureau Veritas Enhance Safety and Compliance
The partnership ensures Iron Fuel Technology meets high safety and compliance standards, supporting its transition from innovation to industrial-scale deployment.
16 October 2025
Carbon Centric Opens Norway's First Carbon Capture Facility
The Rakkestad facility captures CO₂ from waste-to-energy, producing food-grade CO₂. It highlights rapid industrial carbon capture implementation and future expansion plans.
16 October 2025
E3 Lithium and Axens Sign MOU for Lithium Carbonate Sale and Sorbent Supply
The MOU outlines plans for E3 to supply lithium carbonate and Axens to provide a lithium sorbent, aiming for secure supply chains and future definitive agreements.
16 October 2025
Repsol and Forestalia Launch Major Hybrid Energy Project in Aragon
Hybrid project in Aragon combines 818 MW power plant with 805 MW wind farms, optimizing grid use and supporting a nearby data center with renewable energy.
16 October 2025
Johnson & Johnson's AKEEGA® Gets FDA Priority Review for BRCA-Mutated Prostate Cancer
FDA grants Priority Review to AKEEGA® for BRCA-mutated prostate cancer, showing reduced progression risk and improved outcomes in Phase 3 study.
16 October 2025
Merck's KEYNOTE-B96 Trial Shows Improved Survival in Platinum-Resistant Ovarian Cancer
The trial showed improved overall survival with KEYTRUDA in platinum-resistant ovarian cancer, with consistent safety and no new signals. Results to be presented at a future medical meeting.
16 October 2025
Sasol and Topsoe Partner on E-Fuels Plant in Germany
A new e-fuels plant in Germany will produce 2500 tons annually, using renewable feedstocks, with €130 million funding from the German government. Completion is expected by Q4 2027.
16 October 2025
Nobian Enhances Frankfurt Site's Energy Efficiency with Flexible Production
The site adjusts chlor-alkali production to electricity availability, aiding grid stability and reducing costs, while maintaining safety and aiming for climate neutrality by 2040.
16 October 2025
Nouryon Boosts China Operations with Metal Alkyls Expansion and New Innovation Center
Nouryon invests in China to meet polymer demand, doubling triethylaluminum capacity, starting MMAO production, and opening an organic peroxides innovation center.
16 October 2025
Equinor Begins Production at Bacalhau Field
Bacalhau field in Brazil starts production with over 1 billion boe reserves, using advanced FPSO technology for efficient, low-emission output. Expected to create 50,000 jobs over 30 years.
15 October 2025
Rain Carbon Canada and Green Graphite Technologies team on NGen grant for sustainable graphite anodes
Project to recycle, purify and manufacture graphite anode materials to build a circular supply chain for Canada’s EV and stationary storage markets.
15 October 2025
Pearl Petroleum Boosts Khor Mor Gas Capacity by 50%
KM250 project adds 250 MMscf/d capacity, increasing Khor Mor's output to 750 MMscf/d, meeting over 80% of Kurdistan's power needs. Delivered eight months ahead of schedule.
15 October 2025
Novo Nordisk Acquires Rights to Omeros' MASP-3 Inhibitor Zaltenibart
Zaltenibart, a MASP-3 inhibitor, targets rare blood and kidney disorders. Omeros receives up to $2.1 billion, plus royalties. Novo Nordisk plans global phase 3 trials.
15 October 2025
Merck Reports Phase 3 Trial Data on Doravirine-Islatravir Regimen
Phase 3 trials show minimal weight, body composition, and lipid changes with the DOR/ISL regimen in HIV-1 patients, maintaining viral suppression without resistance.
15 October 2025
Stahl Reopens Ranipet Facility in India for Sustainable Growth
The upgraded facility focuses on local production, innovation, and sustainability, enhancing R&D and customer collaboration in a key growth market.
14 October 2025
Uniper Advances Green Hydrogen Production at Bad Lauchstädt
The Bad Lauchstädt Energy Park nears completion with its 30 MW electrolyzer, set to produce 4,000 tons of green hydrogen annually, supporting Germany's energy transition.
14 October 2025
Lhyfe Launches Germany's Largest Renewable Hydrogen Site
Lhyfe's new site in Schwäbisch Gmünd produces 4 tons of renewable hydrogen daily, aiming to decarbonize transport and industry, supported by EU and state funding.
14 October 2025
ECLUSE Completes Belgium's Longest Microtunnel
The ECLUSE tunnel under the Scheldt is complete, enabling steam transport from waste-to-energy facilities to Evonik, reducing CO₂ emissions and supporting Antwerp's energy transition.
14 October 2025
PureCycle Gains EU REACH Certification for PureFive™ Resin Sales
PureFive™ resin meets EU standards, enabling sales in Europe. Demand grows as PureCycle plans a facility in Belgium by 2028. Current production in Ohio supports diverse applications.
14 October 2025
Merus Publishes Abstract on Petosemtamab for Metastatic Colorectal Cancer at AACR-NCI-EORTC Conference
Petosemtamab shows antitumor activity and manageable safety in mCRC trials, with ongoing data updates to be presented at the conference.
14 October 2025
Mitsubishi Chemical Completes Pilot Wastewater Treatment Facility at Hiroshima Plant
The facility aims to develop cost-effective wastewater treatment technology to reduce COD, with potential for global deployment and future commercialization.
13 October 2025
Hydrogen Supply and Demand in Northern Netherlands: Progress and Challenges for RWE
Green hydrogen projects face delays due to uncertain demand and regulatory hurdles, impacting investment decisions and progress in the northern Netherlands.
← Previous
Next →
